Radiofrequency Ablation of Metastases from Renal Cell Carcinoma: Technique, Complications, and Midterm Outcome

European Urology, Supplements

Volumn 6, Issue 10, 2007, Pages 653-657

  Kloeters, Christian ^a   Mager, Ann Kathrin ^a   Johannsen, Manfred ^a   Ringsdorf, Martin ^a   Roemer, Andreas ^a   Tuellmann, Maximilian ^a   Hamm, Bernd ^a   Hein, Eike ^a   Rogalla, Patrik ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Image guidance; Metastases; Radiofrequency ablation; Renal cancer

Indexed keywords

IOBITRIDOL;

ADRENAL METASTASIS; ADULT; ARTICLE; CANCER CONTROL; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FOLLOW UP; HUMAN; KIDNEY CARCINOMA; LIVER METASTASIS; LUNG METASTASIS; OPERATING ROOM PERSONNEL; PNEUMOTHORAX; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; SOFT TISSUE METASTASIS; TREATMENT OUTCOME; TUMOR VOLUME;

EID: 34247253889     PISSN: 15699056     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eursup.2007.03.011     Document Type: Article

References (17)

1. Sutherland L.M., Williams J.A., Padbury R.T., et al. Radiofrequency ablation of liver tumors: a systematic review. Arch Surg 141 (2006) 181-190
2. Gervais D.A., McGovern F.J., Arellano R.S., et al. Radiofrequency ablation of renal cell carcinoma. Part 1: Indications, results, and role in patient management over a 6-year period and ablation of 100 tumors. AJR Am J Roentgenol 185 (2005) 64-71
3. Gervais D.A., McGovern F.J., Arellano R.S., et al. Radiofrequency ablation of renal cell carcinoma. Part 2: lessons learned with ablation of 100 tumors. AJR Am J Roentgenol 185 (2005) 72-80
4. Matin S.F., Ahrar K., Cadeddu J.A., et al. Residual and recurrent disease following renal energy ablative therapy: a multi-institutional study. J Urol 176 (2006) 1973-1977
5. Rogalla P., and Juran R. CT fluoroscopy. Radiologe 44 (2004) 671-675
6. de Baere T., Palussiere J., Auperin A., et al. Midterm local efficacy and survival after radiofrequency ablation of lung tumors with minimum follow-up of 1 year: prospective evaluation. Radiology 240 (2006) 587-596
7. Steinke K., Sewell P.E., Dupuy D., et al. Pulmonary radiofrequency ablation: an international study survey. Anticancer Res 24 (2004) 339-343
8. Hiraki T., Yasui K., Mimura H., et al. Radiofrequency ablation of metastatic mediastinal lymph nodes during cooling and temperature monitoring of the tracheal mucosa to prevent thermal tracheal damage: initial experience. Radiology 237 (2005) 1068-1074
9. Aron M., and Gill I.S. Minimally invasive nephron-sparing surgery (MINSS) for renal tumours. Part II: probe ablative therapy. Eur Urol 51 (2007) 348-357
10. Vogl U.M., Zehetgruber H., Dominkus M., et al. Prognostic factors in metastatic renal cell carcinoma: metastasectomy as independent prognostic variable. Br J Cancer 95 (2006) 691-698
11. van der Poel H.G., Roukema J.A., Horenblas S., et al. Metastasectomy in renal cell carcinoma: a multicenter retrospective analysis. Eur Urol 35 (1999) 197-203
12. Mouraviev V., Joniau S., Van Poppel H., and Polascik T.J. Current status of minimally invasive ablative techniques in the treatment of small renal tumours. Eur Urol 51 (2007) 328-336
13. Chang I., Mikityansky I., Wray-Cahen D., et al. Effects of perfusion on radiofrequency ablation in swine kidneys. Radiology 231 (2004) 500-505
14. Lee J.M., Kim S.H., Han J.K., et al. Ex vivo experiment of saline-enhanced hepatic bipolar radiofrequency ablation with a perfused needle electrode: comparison with conventional monopolar and simultaneous monopolar modes. Cardiovasc Intervent Radiol 28 (2005) 338-345
15. Gillams A.R. Complications of percutaneous therapy. Cancer Imaging 21 (2005) 110-113
16. Rohde D., Albers C., Mahnken A., et al. Regional thermoablation of local or metastatic renal cell carcinoma. Oncol Rep 10 (2003) 753-757
17. Mickisch G., Carballido J., Hellsten S., et al. European Association of Urology: guidelines on renal cell cancer. Eur Urol 40 (2001) 252-255